This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
ChemoCentryx
CCXI
$51.99
Share price
0.00%
Change (1 day)
33.72%
Change (1 year)
Categories
Market capitalization of ChemoCentryx (CCXI)
Last known market cap: $3.73 Billion USD
On November 25, 2022 ChemoCentryx had a market cap of $3.73 Billion USD. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of ChemoCentryx from 2012 to 2022
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2022 | $3.73 B | 46.64% |
| 2021 | $2.54 B | -40.5% |
| 2020 | $4.28 B | 79.89% |
| 2019 | $2.38 B | 331.09% |
| 2018 | $0.55 B | 90.45% |
| 2017 | $0.29 B | -17.98% |
| 2016 | $0.35 B | -1.16% |
| 2015 | $0.35 B | 20.61% |
| 2014 | $0.29 B | 19.5% |
| 2013 | $0.24 B | -37.56% |
| 2012 | $0.39 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | $18.00 B | 381.43% | 🇺🇸 USA |
 | $330.72 B | 8,745.12% | 🇺🇸 USA |
 | $74.19 B | 1,884.31% | 🇬🇧 UK |
 | $112.52 B | 2,909.34% | 🇺🇸 USA |
 | $369.28 B | 9,776.31% | 🇺🇸 USA |
 | $158.14 B | 4,129.56% | 🇺🇸 USA |
 | $130.27 B | 3,384.07% | 🇺🇸 USA |
 | $16.07 B | 329.84% | 🇮🇱 Israel |
 | $205.79 B | 5,403.90% | 🇺🇸 USA |